博拓生物: 博拓生物关于2024年员工持股计划预留股份非交易过户完成的公告

Core Viewpoint - The company has successfully completed the non-trading transfer of shares for its 2024 employee stock ownership plan, indicating a commitment to employee engagement and investment in the company's future [1][2][3]. Group 1: Employee Stock Ownership Plan - The company held meetings on September 25, 2024, to approve the implementation of the 2024 employee stock ownership plan [1]. - A total of 1,900,000 shares were transferred to the employee stock ownership plan account at a price of 13.09 yuan per share on December 3, 2024 [2]. - The management committee approved the allocation of reserved shares, with 250,000 shares designated for 64 employees at a price of 12.59 yuan per share [3]. Group 2: Share Transfer and Lock-up Period - An additional 250,000 shares were transferred to the employee stock ownership plan account on May 16, 2025, at the same price of 12.59 yuan per share, bringing the total shares held under the plan to 2,150,000, which represents 2.0156% of the company's total share capital [4]. - The shares acquired under the plan will be unlocked in three phases over 12, 24, and 36 months, with respective unlock ratios of 40%, 30%, and 30% [4]. - The plan will terminate automatically if not extended after its maximum duration, ensuring a structured approach to employee equity participation [4][5].